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ÖZET
Otuz iki yaşında yedi haftalık multipar gebe bir kadın, acil servi-
simize 35 dakika önce başlayan göğüs ağrısı şikayeti ile başvur-
du. Hasta bekleme odasında beklerken ani kardiyak arrest gelişti. 
Kardiopulmoner resüsitasyon yapılıp hasta hemen entübe edildi. 
Elektrokardiyografide inferior miyokart enfaktüsü saptandı. Has-
taya koroner anjiyografi yapıldı ve sirkumfleks arter ile sol ön inen 
arterde yavaş akım izlendi. Medikal tedavide asetilsalisilik asit ve 
klopidogrel kombinasyonu ile unfraksiyone heparin başlandı. Has-
tamız üç tane sağlıklı çocuğa sahipti ve önceki gebeliklerinde her-
hangi bir problem yaşamamıştı. Risk faktörlerinden aile öyküsü ve 
sigara içiciliği mevcuttu ancak diyabetes mellitus, hipertansiyon, 
dislipidemi yoktu. Çıkış tedavisi asetilsalisilik asit, klopidogrel ve 
beta bloker olarak düzenlendi ve yatışının beşinci gününde sıkı ta-
kip önerildi. Miyakart enfaktüsündan iki hafta sonra elektif abor-
tus planlandı.
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SUMMARY
A 32-year-old multiparous woman who presented with chest pain 
at seven weeks gestation was admitted to our hospital 35 minutes 
after the onset of symptoms. Sudden cardiac arrest developed 
while the patient was waiting in the triage room. Cardiopulmonary 
resuscitation was performed, and the patient was immediately intu-
bated. Electrocardiography revealed an inferior myocardial infarc-
tion. The patient underwent coronary angiography, which revealed 
slow coronary flow of the circumflex and left anterior descending 
coronary arteries. For treatment, the combination of aspirin with 
clopidogrel and unfractionated heparin was initiated. She had pre-
viously had three healthy children and hadn’t had any problems 
during her previous pregnancies. She had a history of family and 
smoking, but no history of other coronary risk factors such as dia-
betes mellitus, hypertension, or dyslipidemia. She was discharged 
home on day five after admission with clopidogrel, aspirin and a 
beta-blocker with close outpatient follow-up. Elective abortion was 
planned for two weeks after the myocardial infarction.
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Introduction
Acute myocardial infarction (AMI) during pregnancy is rare 
but serious condition that it is a cause of maternal mortality 
and fetal loss. Pregnancy has been shown to increase the risk 
of AMI, which has been reported to occur in 3-10 cases per 
100,000 deliveries.[1-4] With the rise in maternal age and the 
increasing number of high-risk women who become preg-
nant, the prevalence of pregnancy-related acute coronary 
syndrome (ACS) is expected to increase. Pregnancy leads to 
excessive hypercoagulability by increasing platelet adhesi-
on and decreasing fibrinolysis; these hemostatic changes 
lead to an increased risk of thromboembolic events.[3-5] It is 
strongly related to the traditional risk factors of coronary he-
art disease, including diabetes mellitus, hypertension, dysli-
pidemia, family history of coronary artery disease and smo-
king. Additionally, other conditions that contribute to ACS 
are preeclampsia, eclampsia, thrombophilia, postpartum in-
fections, severe postpartum hemorrhage, and spontaneous 
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coronary artery dissections.[4] Maternal mortality after ACS is 
estimated to be 5-10% and is highest during the peripartum 
period. Survival has improved with primary percutaneous 
coronary intervention (PCI).[2-4]
This article accompanies pregnancy in patients with ST ele-
vation myocardial infarction (STEMI), and we consider a ge-
neral approach to treatment.
Case Report
A 32-year-old multiparous woman at seven weeks gestation 
presented to the Emergency Department (ED) with a sudden 
onset of chest pain within the previous 35 minutes. She had 
three healthy children and had no problems during previo-
us pregnancies. She had a family history of coronary artery 
disease but no history of other coronary risk factors such as 
diabetes mellitus, hypertension, dyslipidemia or smoking. 
Sudden cardiac arrest developed while she was waiting in 
the triage room. Cardiopulmonary resuscitation (CPR) was 
performed and patient was immediately intubated. Vent-
ricular fibrillation developed during CPR and defibrillation 
was performed. Clinical examination showed she had flexor 
response to painful stimuli and her pupillary light reflex was 
present. Her blood pressure was 90/55 mmHg with a pulse of 
102 beats per minute, oxygen saturation of 96%, and normal 
heart sounds. There were ST elevations in leads DII, DIII, and 
aVF; conversely ST depression in leads V1-V4; and atrial fib-
rillation (AF) on electrocardiography (ECG) following CPR (Fi-
gure 1a, b). Portabilizer echocardiography was performed in 
the emergency department by cardiologists. The echocardi-
ogram demonstrated that the wall motions were severely re-
duced in the inferior and lateral regions, consistent with AMI, 
and the estimated ejection fraction of the left ventricle was 
40%. With the diagnosis of an inferior STEMI, aspirin (300 mg) 
and clopidogrel (600 mg) were given in the ED. The patient 
was then referred for primary angioplasty, which was perfor-
med within 45 minutes. Catheterization was performed after 
shielding the patient’s back and abdomen with lead aprons. 
Coronary angiography showed slow coronary flow of the cir-
cumflex (CX) and left anterior descending (LAD) coronary ar-
teries. Right coronary artery was normal (Figure 2). The com-
bination of aspirin (100 mg/day) with clopidogrel (75 mg/day 
for 2 weeks) and unfractionated heparin was initiated for me-
dical treatment. Biochemistry tests [urea, creatinine, glucose, 
aspartate aminotransferase (AST), alanine aminotransferase 
(ALT)] were normal, except for mild leukocytosis. The serum 
levels of troponin peaked at 13 ng/ml.
We consulted an obstetrician regarding the safety of admi-
nistering clopidogrel and the use of radiation after angiog-
raphy. and both were consequently considered to be unsafe 
because organogenesis was not complete. She was disc-
harged home on day five after admission with clopidogrel, 
aspirin and a beta-blocker with close outpatient follow-up. 
Elective abortion was planned for two weeks after the MI.
There was no prior history of connective tissue disease, vas-
culitis, impaired anticoagulant mechanism (protein C defi-
ciency, protein S deficiency), or antiphospholipid antibody 
syndrome, which are associated with a thrombotic ten-
dency. Birth control pills had never been used. Immunologic 
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Figure 1. (a, b) Atrial fibrillation (AF) and  ST elevations in leads DII, DIII, and aVF; conversely ST depres-
sion in leads V1-V4 on electrocardiography (ECG)  following CPR.
(b)
(a)
tests performed prior to admission, which included antip-
hospholipid antibodies, were negative.
Discussion
There are few published statistics concerning acute myocar-
dial infarction (AMI) in pregnant women. The incidence of 
AMI in pregnancy ranges from 3-6 cases per 100,000 deli-
veries.[1-4] A previous review demonstrated that pregnancy-
associated AMI occurs at all stages of pregnancy. It is more 
common late in pregnancy, with a peak incidence during 
the peripartum or postpartum period. This may be due to 
the fact that, during this period, there is also a higher oc-
currence of hypertension and preeclampsia, which are the 
most important risk factors for AMI in these patients.[4] In 
our patient, however, the event was occurred relatively early, 
in the first trimester of pregnancy.
The physiopathology of ACS in pregnant women is quite 
different from the normal population. Pregnancy-associa-
ted AMI has been thought to be related to both an excess 
procoagulant state and increased stress on the cardiovascu-
lar system, leading to coronary thrombosis or spontaneous 
coronary dissection.[3-5] A study by Roth et al. reviewed co-
ronary lesions in pregnant patients with ACS. The following 
results were revealed: 39% of arteries had atherosclerotic 
lesions, 19% were found to have an intracoronary thrombus 
without any other lesion, 15% had a coronary dissection, 
and 27% of the arteries were apparently normal.[4] As can be 
seen, contrary to the rest of the population, a much higher 
proportion of normal coronary arteries and intracoronary 
dissections are the cause of the coronary syndrome.[4] Para-
doxical coronary embolism through a patent foramen ovale 
is an additional potential mechanism of myocardial infarcti-
on during pregnancy, although this case showed clear-cut 
coronary artery disease. Ladner et al. identified hyperten-
sion, diabetes, advanced maternal age, preeclampsia and 
eclampsia as independent risk factors for pregnancy-asso-
ciated AMI, and James et al. also found that thrombophilia, 
transfusion, and postpartum infections were significant risk 
predictors for AMI.[2,3] Spontaneous coronary artery dissecti-
ons are more prevalent among pregnant than non-pregnant 
women, and are mostly reported around delivery or in the 
early postpartum period.[4] They may be related to high pro-
gesterone levels with subsequent structural changes in the 
collagen of the vessel wall. Ergometrine given for bleeding 
postpartum may lead to coronary vasospasm and ischemia. 
Thrombi and dissections occur more frequently in the peri-
partum period than in delivery.[4] Although our patient was 
young and did not have any risk factors for pregnancy-asso-
ciated AMI, percutaneous coronary angiogram demonstra-
ted normal coronary arteries with slow flow in circumflex, 
the ECG was STEMI.
Maternal mortality after ACS is estimated at 5-10% and is 
highest during the peripartum period. Survival has imp-
roved with PCI.[2-4] Long-term maternal prognosis mainly 
depends on the severity of maternal heart disease and the 
cardiovascular risk profile. Before delivery, ACS may result in 
fetal mortality or prematurity.
The first step during pregnancy in ST-elevation ACS is a pri-
mary PCI, which is preferred to thrombolysis as it will also 
diagnose coronary artery dissection. Although recombinant 
tissue plasminogen activator does not cross the placenta, it 
may induce bleeding complications such as subplacental 
bleeding; therefore, thrombolytic therapy should be reser-
ved for life-threatening ACS when there is no access to PCI.[6]
The risk of potential damage to the fetus should be kept in 
mind, especially in the first trimester. However, this can be 
overcome with the use of appropriate radiological protecti-
on. In our case, a decision was taken to use lead apron pro-
tection. The patient’s abdomen was covered and, to protect 
the fetus from excessive radiation, additional protection was 
also placed between the patient’s back and the table.
β-Blockers and low dose acetylsalicylic acid are considered 
to be relatively safe during both the second and third trimes-
ters, while the safety profile is unknown for thienopyridines.
[7] Heparin does not cross the placenta, and several reports 
have demonstrated that heparin is safe to use during preg-
nancy.[8]
In conclusion, AMI in pregnancy is a rare event with specific 
features that are related to both an excess procoagulant sta-
te and increased stress on the cardiovascular system, leading 
to coronary thrombosis or spontaneous coronary dissecti-
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Figure 2. Coronary angiography showed slow coronary flow of the
circumflex (Cx) and left anterior descending (LAD) coronary arteries.
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on. Understanding the causes of pregnancy-related acute 
myocardial infarction and identification of women at risk 
are the first steps for prevention. Screening and preventive 
measures should focus on women with advanced maternal 
age, known coronary risk factors, thrombophilia, postpar-
tum complications, and being a smoker. Family history and 
smoking are the most important risk factors, and these have 
a higher-than-normal rate for non-atherosclerotic coronary 
disease in these groups. Management of these patients sho-
uld include the use of bare-metal stents, precaution with the 
use of antiplatelet therapy, and appropriate protection du-
ring radiological procedures.
Our patient had normal coronary artery with slow coronary 
flow and drug treatment was administered. Elective aborti-
on was planned for two weeks after the MI.
This article suggests that acute coronary syndrome should 
be considered in pregnant women who have chest pain. In 
these patients, the ECG should be performed immediately.
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